These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 20220043)

  • 1. Novel avenues of drug discovery and biomarkers for diabetes mellitus.
    Maiese K; Chong ZZ; Shang YC; Hou J
    J Clin Pharmacol; 2011 Feb; 51(2):128-52. PubMed ID: 20220043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel directions for diabetes mellitus drug discovery.
    Maiese K; Chong ZZ; Shang YC; Wang S
    Expert Opin Drug Discov; 2013 Jan; 8(1):35-48. PubMed ID: 23092114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus: channeling care through cellular discovery.
    Maiese K; Shang YC; Chong ZZ; Hou J
    Curr Neurovasc Res; 2010 Feb; 7(1):59-64. PubMed ID: 20158461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.
    Maiese K
    Biomed Pharmacother; 2008; 62(4):218-32. PubMed ID: 18342481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired nicotinamide adenine dinucleotide (NAD
    Fan L; Cacicedo JM; Ido Y
    J Diabetes Investig; 2020 Nov; 11(6):1403-1419. PubMed ID: 32428995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards newer molecular targets for chronic diabetic complications.
    Khan ZA; Farhangkhoee H; Chakrabarti S
    Curr Vasc Pharmacol; 2006 Jan; 4(1):45-57. PubMed ID: 16472176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead Optimization Resources in Drug Discovery for Diabetes.
    Tiwari P; Katyal A; Khan MF; Ashraf GM; Ahmad K
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):754-774. PubMed ID: 30834844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and diabetes mellitus.
    Yang H; Jin X; Kei Lam CW; Yan SK
    Clin Chem Lab Med; 2011 Nov; 49(11):1773-82. PubMed ID: 21810068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide adenine dinucleotide phosphate oxidase and diabetes: vascular implications.
    Maier KG
    Vasc Endovascular Surg; 2008; 42(4):305-13. PubMed ID: 18621880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
    Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
    Cooper GJ
    Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery aspects of antioxidants in diabetes management.
    Duvvuri LS; Katiyar S; Kumar A; Khan W
    Expert Opin Drug Deliv; 2015 May; 12(5):827-44. PubMed ID: 25582375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.
    Endemann DH; Schiffrin EL
    Curr Hypertens Rep; 2004 Apr; 6(2):85-9. PubMed ID: 15010009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging applications of metabolomics in drug discovery and precision medicine.
    Wishart DS
    Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes.
    Miao Y; Smink PA; de Zeeuw D; Lambers Heerspink HJ
    Clin Chem; 2011 Feb; 57(2):186-95. PubMed ID: 21159899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms behind the anti-inflammatory actions of insulin.
    Hyun E; Ramachandran R; Hollenberg MD; Vergnolle N
    Crit Rev Immunol; 2011; 31(4):307-40. PubMed ID: 21899513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TZD insulin sensitizer clue provides a new route into diabetes drug discovery.
    Colca JR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1259-70. PubMed ID: 26479699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.